Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Genetether Therapeutics Inc. (GTTX.CN)

Genetether Therapeutics Inc. (GTTX.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 9,557
  • Shares Outstanding, K 47,784
  • Annual Sales, $ 0 K
  • Annual Income, $ -1,638 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.49
Trade GTTX.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.04
  • Most Recent Earnings -0.01 on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.200 unch
on 06/30/22
0.400 -50.00%
on 06/16/22
-0.120 (-37.50%)
since 05/30/22
3-Month
0.200 unch
on 06/30/22
0.590 -66.10%
on 03/31/22
-0.800 (-80.00%)
since 03/30/22

Most Recent Stories

More News
The Power Play by The Market Herald Releases New Interview with GeneTether Therapeutics

VANCOUVER, BC / ACCESSWIRE / May 30, 2022 / The Power Play by The Market Herald has announced the release of a new interview with GeneTether Therapeutics on their latest news.

GTTX.CN : 0.200 (-4.76%)
GeneTether Therapeutics Announces Issuance of New US Composition of Matter Patent for its Innovative Platform Technology Focused on Gene Editing Efficiency

/CNW/ - GeneTether Therapeutics Inc., ("GeneTether" or the "Company") (CSE: GTTX) announced today that the United States Patent and Trademark Office has...

GTTX.CN : 0.200 (-4.76%)
The Power Play by The Market Herald Releases Interviews With Monarch Mining, Vox, Tocvan Ventures, GeneTether Therapeutics, Peloton Minerals, SWMBRD Sports, and BioVaxys Technology Corp.

VANCOUVER, BC / ACCESSWIRE / March 30, 2022 / The Power Play by The Market Herald has announced the release of new interviews with Monarch Mining, Vox, Tocvan Ventures, GeneTether Therapeutics, Peloton...

GBAR.TO : 0.4050 (-6.90%)
VOX.VN : 2.810 (-1.06%)
TOC.CN : 0.830 (-1.19%)
GTTX.CN : 0.200 (-4.76%)
PMC.CN : 0.060 (unch)
SWIM.CN : 0.085 (unch)
BIOV.CN : 0.100 (-4.76%)

Key Turning Points

3rd Resistance Point 0.200
2nd Resistance Point 0.200
1st Resistance Point 0.200
Last Price 0.200
1st Support Level 0.200
2nd Support Level 0.200
3rd Support Level 0.200

See More

52-Week High 1.000
Fibonacci 61.8% 0.694
Fibonacci 50% 0.600
Fibonacci 38.2% 0.506
Last Price 0.200
52-Week Low 0.200

See More

Business Summary

GeneTether Therapeutics Inc is an innovative genetic medicines company focused on the development of high-efficiency precision gene editing for human therapeutics applications. . It is engaged in creating best-in-class gene-editing therapies based on the proprietary GeneTether platform. Further, it is...

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar